Short description
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics.
Description
Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics. The company focuses on developing modified T-cell receptor therapeutics and dendritic cell vaccines that target tumor antigens to improve tumor cells therapy and treatment.
Total funding
$$3123123
Sign in for full access
Location
Shanghai, Shanghai, China, Asia
Founded on
April 1, 2019
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noway Youcantaccess, No Way, Noaccessforu, No Way
Sign in for full access
Founders
Xinan Chen